Skip to main content
SpringerLink
Log in

Unrecognized blood clotting factors

  • Review Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Most clotting factors were initially discovered as agents functionally deficient in the plasmas of rare patients with hereditary coagulation disorders. During 1940s to 1960s, many factors were named by different investigators after the name of the patient who lacked a new factor. Consequently, there were the same factors with different names. To avoid confusion, the International Committee on the nomenclature of clotting factors was founded and discussed the identity or non-identity of clotting factors by specialists. There remain, however, several factors that were not officially authorized. We attempt to review some of these factors that seem to be not identical with any known clotting factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wright IS. The nomenclature of blood clotting factor. Can Med Assoc J. 1962;86:373–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Sherry S. The founding of The International Society on Thrombosis and Haemostasis: how it came about. Thromb Haemosta. 1990;64:188–91.

    Article  CAS  Google Scholar 

  3. Hougie C, McPherson RA, Aronson L. Passovoy factor: a hitherto unrecognized factor necessary for haemostasis. Lancet. 1975;2:290–1.

    Article  CAS  Google Scholar 

  4. Hougie C, McPherson RA, Brown JE, Larkin-Thomas PL, Melaragno A, Aronson L, et al. The Passovoy defect: further characterization of a hereditary hemorrhagic diathesis. N Engl J Med. 1978;298:1045–8.

    Article  CAS  Google Scholar 

  5. Jackson JM, Marshall LR, Herrmann RP. Passovoy factor deficiency in five Western Australian kindreds. Pathology. 1981;13:517–24.

    Article  CAS  Google Scholar 

  6. Foster PA, Montgomery RR, Endres-Brooks J. Multiple coagulation factor abnormalities in commercially available Passovoy-deficient plasma. Blood. 1992;80:3260–1.

    Article  CAS  Google Scholar 

  7. Hayani A, Suarez CR, Godwin JE, Blakemore C. Testing for Passovoy defect in children with prolonged activated partial thromboplastin time (APTT). J Pediatr Hematol Oncol. 1996;18:262–5.

    Article  CAS  Google Scholar 

  8. Triplett DA. Evaluation of the minimally prolonged APTT: Passovoy factor or lupus anticoagulant? J Pediatr Hematol Oncol. 1996;18:247–8.

    Article  CAS  Google Scholar 

  9. Bick RL, Adams T, Goldberg LS. Evidence for a new activation phase clotting abnormality in a patient with the Hughes–Stoven syndrome. Beitr Pathol. 1974;153:310–7.

    Article  CAS  Google Scholar 

  10. Nishi K, Myou S, Ooka T, Taitou H, Fujimura M, Matsuda T. A case of Behcet’s disease presenting with Hughes–Stovin Syndrome. Jpn J Thorac Dis. 1993;13:379–84.

    Google Scholar 

  11. Yoshida K, Fukui H, Umegaki K, Kamisue M. Separation of Nishimine factor from fibrinogen and factor VIII (AHF) by the DEAE-cellulose column chromatography. J Nara Med Assoc. 1961;12:1165–72.

    Google Scholar 

  12. Yoshida K, Fukui H, Tagawa N, Kamisue M. Separation of Tatsumi factor from factor IX (PTC), factor X and factor VII-complex by the DEAE-cellulose column chromatography. J Nara Med Assoc. 1961;12:1173–9.

    Google Scholar 

  13. Chirico AM, McElfresh AE. A possible new thromboplastin deficiency occurring in five siblings. Blood. 1957;12:933–41.

    Article  CAS  Google Scholar 

  14. Greig HB, Tattersall JC. Evidence for the existence of a third serum clotting factor. Br J Haematol. 1956;2:421–9.

    Article  CAS  Google Scholar 

  15. Spaet TH, Aggeler PM, Kinsell BG. A possible fourth plasma thromboplastin component. J Clin Investig. 1954;33:1095–102.

    Article  CAS  Google Scholar 

  16. Quick AJ, Stanley-Brown M, Bancroft FW. A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci. 1935;190:501–11.

    Article  Google Scholar 

  17. Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol. 1961;36:212–9.

    Article  CAS  Google Scholar 

  18. Saito H. Studies on Fletcher trait and Fitzgerald trait. A rare chance to disclose body’s defense reactions against injury. Thromb Haemost. 2010;104:867–74.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Hospital Organization Nagoya Medical Center, 4-1-1 Sanno-maru, Naka-ku, Nagoya, 460-0001, Japan

    Hidehiko Saito

  2. Aichi Health Promotion Foundation, 1-18-4 Shimizu, Kita-ku, Nagoya, 462-0844, Japan

    Tetsuhito Kojima

Authors
  1. Hidehiko Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsuhito Kojima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hidehiko Saito.

Ethics declarations

Conflict of interest

We have no conflict of interest in this paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saito, H., Kojima, T. Unrecognized blood clotting factors. Int J Hematol 113, 785–788 (2021). https://doi.org/10.1007/s12185-021-03133-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-021-03133-7

Keywords

Search

Navigation